Addendum: A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial

Oncotarget. 2022 Aug 4:13:983. doi: 10.18632/oncotarget.28263.
No abstract available

Publication types

  • Published Erratum